Palabras clave
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: describir los costos de hospitalizaciones con el uso de stents vasculares periféricos en el sistema público de salud brasileño entre los años 2008-2017. Métodos: estudio retrospectivo, ecológico, con análisis de series de tiempo, obtenidas del Departamento de Informática del Sistema Único de Salud (DATASUS) sobre hospitalizaciones y gastos en el uso de implantes de stent vascular realizados en enfermedad arterial periférica (EAP). Resultados: Durante el periodo de estudio se registraron un total de 36.543 hospitalizaciones por EAP. Se observó un aumento rápido y progresivo en el uso de stents entre los años del estudio, siendo las regiones sureste (45,7%) y sur (36,8%) responsables del 82,5% de las hospitalizaciones. La angioplastia intraluminal de vasos de las extremidades con stent descubierto fue la más prevalente (70%) y la de mayor costo total. Conclusión: El uso de stents vasculares se ha incrementado progresivamente entre los años del estudio, generando un impacto significativo en términos de ocupación y gasto hospitalario.
Referencias
AGÊNCIA NACIONAL DE SAÚDE SUPLEMENTAR DO BRASIL. Sala de Situação. 2022 [Acessado em 30 de março 2023]. Disponível em: https://www.gov.br/ans/pt-br/assuntos/noticias/numeros-do-setor/sala-de-situacao-ans-disponibiliza-dados-de-setembro
ALVIM RO, et al. Prevalence of peripheral artery disease and associated risk factors in a Brazilian rural population: the Baependi Heart Study. Int J Cardiovasc Sci., 2018; 31: 405-13.
ALZAMORA MT, et al. Incidence of peripheral arterial disease in the ARTPER population cohort after 5 years of follow-up. BMC Cardiovasc Disord., 2016; 16: 8.
CLAIR DG e BEACH JM. Strategies for managing aortoiliac occlusions: access, treatment and outcomes. Expert Rev Cardiovasc Ther., 2015; 13(5): 551–563.
CONTE SM, VALE PR. Peripheral Arterial Disease. Heart Lung and Circ., 2017; 27(4): 427-432.
DORMANDY JA e RUTHERFORD RB. Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg., 2000; 31: S1–S296.
DUDA SH, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery : long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13(6):701-10.
FANARI Z e WEINTRAUB WS. Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease. Cardiovascular Revascularization Medicine, 2015; 16(7): 421–425.
FU X, et al. Angioplasty versus bypass surgery in patients with critical limb ischemia-a meta-analysis. Int J Clin Exp Med., 2015; 8(7): 10595-602.
GEIGER MA e GUILLAUMON AT. Tratamento da doença arterial obstrutiva periférica em território femoropoplíteo com stent primário: análise em até 24 meses. J Vasc Bras., 2019; 18: e20160104
GERHARD-HERMASNN et al. AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation., 2016; 135(12): e686–e725.
HIRSCH AT. Treatment of peripheral arterial disease — extending “Intervention” to “Therapeutic Choice.”. N Engl J Med. 2006;354(18):1944-7.
KAKKAR AM e ABBOTT JD. Percutaneous Versus Surgical Management of Lower Extremity Peripheral Artery Disease. Curr. Atheroscler. Rep., 2015; 17(2): 2-9.
KATSANOS K, et al. Standards of Practice for Superficial Femoral and Popliteal Artery Angioplasty and Stenting. CardioVascular and Interventional Radiology. 2014; 37(3): 592–603.
KUDAGI VS e WHITE CJ. Endovascular stents: A review of their use in peripheral arterial disease. Am. J. Cardiovasc. Drugs. 2013; 13(3): 199–212.
LOBATO AC. Stents vasculares. In: Lobato AC. Cirurgia endovascular. São Paulo: Instituto de Cirurgia Vascular e Endovascular de São Paulo; 2006; 83-96.
MAKDISSE, M. et al. Prevalência e fatores de risco associados à doença arterial periférica no projeto corações do Brasil. Arq. Bras. Cardiol., 2008; 91(6): 402-414.
NASCIMENTO BR, et al. Trends in Procedure Type, Morbidity and In-Hospital Outcomes of Patients with Peripheral Artery Disease: Data from the Brazilian Public Health System. Ann. Vasc. Surg. 2016; 31: 143–151.
NGU NL, et al. A retrospective cost analysis of angioplasty compared to bypass surgery for lower limb arterial disease in an Australian tertiary health service. J Med Imaging Radiat Oncol. 2018;62(3):337-344.
NGUYEN BN, et al. Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent. J Vasc Surg. 2011;54(4):1051-7.e1.
NORGREN L, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007; 45: S5–S67.
NUNES S e GOUVEIA C. Afinal, não era preciso amputar! Um caso clínico. Rev Port Med Geral Fam. 2018; 34(5): 307-11.
SCHILLINGER M, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879-88.
SELVIN E e ERLINGER TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation, 2004; 110(6): 738-43.
VELESCU A, et al. Peripheral Arterial Disease Incidence and Associated Risk Factors in a Mediterranean Population-based Cohort. The Regicor Study. Eur J Vasc Endovasc Surg., 2016; 51(5): 696-705.
WOLOSKER N, et al. Epidemiological analysis of lower limb revascularization for peripheral arterial disease over 12 years on the public healthcare system in Brazil. J Vasc Bras. 2022;21:e20210215.